≡ Risteys
R10

Documentation Changelog GitHub Contact & Feedback

Basal cell carcinoma, including avohilmo (controls excluding all cancers)

Endpoint Browser PheWeb

C3_BASAL_CELL_CARCINOMA_INCLAVO_EXALLC

No definition available.

Endpoint definition

↥
FinnGen phenotype data

individuals

diagram downward connector

Apply sex-specific rule None

diagram downward connector

Check conditions None

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Primary healthcare outpatient: ICD-10: C44.01, C44.11, C44.21, C44.31, C44.41, C44.51, C44.61, C44.71, C44.81, C44.91

1 out of 7 registries used, show all original rules.

-

diagram downward connector

Check minimum number of events None

-

diagram downward connector
diagram bullet diagram downward connector

Include endpoints

-

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

21089

diagram downward connector
C3_BASAL_CELL_CARCINOMA_INCLAVO_EXALLC

Control definitions

Control exclude C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy C
First used in FinnGen datafreeze DF9

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 21089 10001 11088
Unadjusted prevalence (%) 5.12 4.34 6.10
Mean age at first event (years) 66.74 65.17 68.15

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 1.32 [1.12, 1.55] 7.3e-4 3817
15 years 0.01 0.90 [0.79, 1.02] 1.1e-1 1756
5 years 0.00 1.76 [1.59, 1.95] 8.5e-27 1179
1 year 0.00 2.19 [1.88, 2.55] 6.1e-24 283

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: C3_BASAL_CELL_CARCINOMA_INCLAVO_EXALLC – Basal cell carcinoma, including avohilmo (controls excluding all cancers)
GWS hits: 80

Survival analyses between endpoints

↥

Plot

before Basal cell carcinoma, including avohilmo (controls excluding all cancers)
after Basal cell carcinoma, including avohilmo (controls excluding all cancers)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Basal cell carcinoma, including avohilmo (controls excluding all cancers)

↥

Endpoint not on priority list, no data to show.